Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Wei Wang

Antiangiogenic therapies for malignant pleural mesothelioma.

scientific article published on January 2011

Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.

scientific article

E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor.

scientific article published on 6 May 2011

E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

scientific article

Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.

scientific article

Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity

article

MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer.

scientific article published on 30 January 2017

Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer.

scientific article published on 8 February 2012

MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1.

scientific article

Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network ⬇️

scientific article published on July 18, 2011

Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer

scientific article published on 12 January 2021

The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.

scientific article published on 11 April 2011

Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma.

scientific article

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

scientific article published on 14 September 2020

Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.

scientific article published on 10 January 2011

Paulina is supported by:

About Paulina

Help